BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Visby Medical™ Receives FDA Clearance and CLIA Waiver for Point-of-Care Respiratory Health Test

  February 26, 2025

   · 

  2 min read
• Press Releases

  U.S. Organ Procurement Organizations Recovered Record Number of Organs in 2024 While Looming Federal Policies Jeopardize Patients

  February 26, 2025

   · 

  5 min read
• Press Releases

  Kyowa Kirin Announces Late-Breaking Abstract Presentation at the American Academy of Dermatology Annual Meeting 2025

  February 26, 2025

   · 

  4 min read
• Press Releases

  IAVI and Biofabri/Zendal Announce First Vaccinations in the IMAGINE Clinical Trial, a Large-scale Safety and Efficacy Trial of the Tuberculosis Vaccine Candidate MTBVAC

  February 26, 2025

   · 

  7 min read
• Press Releases

  Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025

  February 26, 2025

   · 

  1 min read
• Press Releases

  Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

  February 26, 2025

   · 

  8 min read
• Press Releases

  Profound Medical Standardizes on AcuityMD Intelligence Platform for MedTech as Foundation for Growing Organization

  February 26, 2025

   · 

  3 min read
• Press Releases

  Argobio and the Institut Pasteur Launch Enodia Therapeutics: A Biotech Company With a New Approach for Targeted Protein Degradation

  February 26, 2025

   · 

  5 min read
• Press Releases

  Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trial

  February 26, 2025

   · 

  10 min read
• Press Releases

  Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market

  February 26, 2025

   · 

  7 min read